Your session is about to expire
← Back to Search
Inspiratory Muscle Training for Respiratory Muscles Performance
Study Summary
This trial will test whether training the muscles used for inspiration can increase a person's endurance while diving, and whether breathing in low concentrations of carbon monoxide can improve the performance of these muscles.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a neuromuscular disease.My physical fitness level is good, as measured by a specific test.You do not smoke cigarettes.I have anemia.I have a blood disorder such as sickle cell disease or trait.You are pregnant.I have heart or lung disease, including high blood pressure.This study is not seeking individuals without any medical condition.
Frequently Asked Questions
How many people can take part in this experiment at once?
"Affirmative. Data hosted on clinicaltrials.gov verifies that this medical study, initially announced on April 14th 2022, is actively seeking participants. Approximately 60 individuals must be enrolled at a single site to complete the trial."
Who qualifies for participation in this medical experiment?
"This clinical trial requires 60 volunteers aged between 18 and 45 who possess a respiratory system. In addition, the participants must be non-smokers with an appropriate hypercapnic ventilatory response as well as have VO2peak of at least thirty five mL.kg-1.min-1 (males) or thirty mL.kg-1.min-1 (females)."
Can individuals still join this research endeavor?
"Per the clinicaltrials.gov website, this study is actively recruiting patients. It was first made available on April 14th 2022 and has since undergone its latest update on May 26th of this year."
Can individuals aged 20 and above participate in this investigation?
"This clinical trial seeks to enrol patients from 18 to 45 years of age. For those younger or older than this range, there are supplementary trials with 1 for minors and 4 targeting seniors."
Share this study with friends
Copy Link
Messenger